UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                      Washington, DC 20549

                            FORM 8-K
                         CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)
JANUARY 22, 2001









                         BEPARIKO BIOCOM
     (Exact name of registrant as specified in its charter)







Nevada                000-27339                   88-0343832
(State of             (Commission           (I.R.S. Employer
organization)         File Number)       Identification No.)

8764 Carlitas Joy Court, Las Vegas, NV 89117
(Address of principal executive offices)

Registrant's telephone number, including area code (702) 228-4688

Registrant's Attorney: Daniel G. Chapman, Esq., 2080 E. Flamingo
Rd., Suite 112, Las Vegas, (702) 650-5660

ITEM 5.   OTHER EVENTS

The  Company has sold out the shares which were being offered  on
its Form SB-2, declared effective on December 22, 1999.

ITEM 6.   RESIGNATIONS OF REGISTRANT'S DIRECTORS

On  January  22,  2001,  the  Company appointed  Mr.  Stephen  T.
Harrington to the Board of Directors, effective immediately.

On  January  22,  2001, the Company accepted the resignations  of
Messrs. Lewis M. Eslick and Paul J.C. Eslick as well as Ms. Patsy
Harting,  as members of the board and as officers of the Company,
effective  immediately. The remaining member did not  immediately
fill the vacancies created by these resignations.

                           SIGNATURES

Pursuant  to the requirements of the Securities Exchange  Act  of
1934,  the Registrant has duly caused this registration statement
to  be  signed  on its behalf by the undersigned, thereunto  duly
authorized.



                           Bepariko BioCom



                           By:/s/ Stephen T. Harrington
                              Stephen T. Harrington, CEO



                           Date: February 2, 2001